4 results match your criteria: "University of Bologna and Sant'Orsola-Malpighi Hospital[Affiliation]"
Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre study.
BMJ Open Gastroenterol
February 2021
Pancreatobiliary Endoscopy and Endosonography Division, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
Background: Although evidence suggests frequent gastrointestinal (GI) involvement during coronavirus disease 2019 (COVID-19), endoscopic findings are scarcely reported.
Aims: We aimed at registering endoscopic abnormalities and potentially associated risk factors among patients with COVID-19.
Methods: All consecutive patients with COVID-19 undergoing endoscopy in 16 institutions from high-prevalence regions were enrolled.
Criteria for diagnosis and attribution of an occupational musculoskeletal disease.
Med Lav
August 2020
Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna; Occupational Health Unit University of Bologna and Sant'Orsola Malpighi Hospital, Bologna, Italy.
Background: Criteria for diagnosis and compensation of occupational musculoskeletal diseases varies widely between countries as demonstrated by the large differences between countries with comparable economics and social systems (for example, within the European Union). Several countries have a list of occupational diseases and sometimes these lists include diagnostic and attribution criteria, but these criteria are usually not very specific, and they may also be very different.
Objectives: The aim of this paper is to explicitly define what are the information needed for an evidence-based diagnosis and attribution of an occupational musculoskeletal disease.
Efficacy, Safety, and Predictors of Direct-acting antivirals in Hepatitis C Virus Patients with Heterogeneous Liver Diseases.
New Microbiol
October 2019
Virology Unit, Pisa University Hospital; Virology Section and Retrovirus Center, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Safety, efficacy, and predictor factors of sustained-virological-response after 24 weeks of new direct-acting antivirals were evaluated in hepatitis C virus patients with different stages of hepatic disease. 260 patients, median age 60 years, of whom 48.1% cirrhotics, 17.
View Article and Find Full Text PDFWorsening of Serum Lipid Profile after Direct Acting Antiviral Treatment.
Ann Hepatol
October 2018
Hepatology Unit. Department of Medical and Surgical Sciences, University of Bologna and Sant'Orsola-Malpighi Hospital, Bologna, Italy.
Introduction: Host lipid metabolism influences viral replication and lifecycle of hepatitis C virus. Our aim was to evaluate changes in glucose and lipid metabolism of patients with chronic hepatitis C after therapy with direct acting antivirals (DAA).
Material And Methods: We considered patients consecutively treated between January and November 2015 recording clinical data at baseline and week 24 of follow-up.